您所在的位置: 首页 >> 专家介绍 >> 高聆

专家介绍

高聆

所在科室:中心实验室

职称: 主任医师   教授

主要经历: 主任医师,二级教授,山东省立医院科研中心二级研究员。美国Case Western Reserve University大学博士后研究员。山东第一医科大学博士生/博士后导师,山东大学博士生导师。泰山学者攀登计划专家,享受国务院政府津贴,全国妇女…

更多

社会兼职

妇幼健康研究会妇女儿童肥胖控制专业委员会 副主任委员

《中国儿童肥胖的评估、治疗和预防指南》专家委员会 副组长

《中华内分泌代谢杂志》编委

中国生物化学分子学会脂质与脂蛋白专业分会 常务委员

中国病理生理学会第九届动脉粥样硬化专业委员会 委员

国际动脉粥样硬化学会中国分会 理事

FINGER 中国多中心联盟项目(FINGER-China Multicenter Alliance)及FINGER-China专家委员会 委员

优势擅长

内分泌与代谢性疾病的基础临床转化研究。

科研成果

1.Yanjing Guo; Meng Zhao; Tao Bo; Shizhan Ma; Zhongshang Yuan; Wenbin Chen; Zhao He; Xu Hou; Jun Liu; Zhenhai Zhang; Qiang Zhu; Qiangxiu Wang; Xiaoyan Lin; Zhongli Yang; Min Cui; Lu Liu; Yujie Li; Chunxiao Yu; Xiaoyi Qi; Qian Wang; Haiqing Zhang; Qingbo Guan; Lifang Zhao; Shimeng Xuan; Huili Yan; Yanliang Lin; Li Wang; Qihang Li; Yongfeng Song*; Ling Gao*; Jiajun Zhao*,Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol, Cell Res, 2019, Feb, 29(2): 151-166. IF 46.297 2.Yongfeng Song#; Chao Xu#; Shanshan Shao; Jun Liu; Wanjia Xing; Jin Xu; Chengkun Qin; Chunyou Li; Baoxiang Hu; Shounan Yi; Xuefeng Xia; Haiqing Zhang; Xiujuan Zhang; Tingting Wang; Wenfei Pan; Chunxiao Yu; Qiangxiu; Wang; Xiaoyan Lin; Laicheng Wang; Ling Gao*; Jiajun Zhao*,Thyroid-stimulating hormone (TSH) regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis, J Hepatol, 2015, May, 62(5): 1171-9. IF 30.083 3.Zhenyu Yao#, Ying Gong#, Wenbin Chen, Shanshan Shao, Yongfeng Song, Honglin Guo, Qihang Li, Sijin Liu, Ximing Wang, Zhenhai Zhang, Qian Wang, Yunyun Xu, Yingjie Wu, Qiang Wan, Xinya Zhao, Qiuhui Xuan, Dawei Wang, Xiaoyan Lin, Jiawen Xu, Jun Liu, Christopher G Proud, Xuemin Wang, Rui Yang, Lili Fu, Shaona Niu, Junjie Kong, Ling Gao*, Tao Bo*, Jiajun Zhao*. Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice. Nat Metab ,2023 Oct;5(10):1706-1725. IF 20.8 4.Wang Xiaolei; Du Heng; Shao Shanshan; Bo Tao; Yu Chunxiao; Chen Wenbin; Zhao Lifang; Li Qiu; Wang Li; Liu Xiaojing; Su Xiaohui; Sun Mingqi; Song Yongfeng*; Gao Ling*; Zhao Jiajun*,Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis, Hepatology, 2018,Jul, 68(1):62-77. IF 17.298 5.Yujie Li; Yongfeng Song; Meng Zhao; YanjingGuo; Chunxiao Yu; WenbinChen; Shanshan Shao; Chao Xu; Xinli Zhou; Lifang Zhao; Zhenhai Zhang; Tao Bo; Yu Xia; G Proud; Xuemin Wang; Li Wang; Jiajun Zhao*; Ling Gao*, A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2, Hepatology, 2017,Aug, 66(2): 481-497. IF 17.298 6.Limin Tian#; Yongfeng Song#; Mingzhao Xing#; Wei Zhang#; Guang Ning; Xiaoying Li; Chunxiao Yu; Chengkong Qin; Jun Liu; Xingsong Tian; Xianglan Sun; Rui Fu; Lin Zhang; Xiujuan Zhang; Yan Lu; Jianwen Zou; Laicheng Wang; Qingbo Guan; Ling Gao*; Jiajun Zhao*,A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-Hydroxy- 3-Methyl-Glutaryl-Coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase a/cyclic adenosine monophosphate–responsive element binding protein pathway, Hepatology, 2010,Oct, 52(4): 1401-9. IF 17.298 7.Liyong Chen#; Furong Wang#; Xianglan Sun; Jing Zhou; Ling Gao*; Yulian Jiao; Xiaolei Hou; Chengyong Qin; Jiajun Zhao*; Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium, , Exp Mol Med, 2010,Mar,42(3): 205-215.. IF 12.153 8.Yongfeng Song*, Ling gao*, Thrombospondin1 As A Potential Therapeutic Target For Human Nonalcoholic Fatty Liver Disease. Ebiomedicine, 2020,Aug;58:102888. IF 11.205 9.Xiaojing Liu; Heng Du; Qiang Chai; Qing jia; Lu Liu; Meng Zhao; Jun Li; Hui Tang; Wenbin Chen; Lifang Zhao; Li Fang; Ling Gao*; Jiajun Zhao*, Blocking mitochondrial cyclophilin D ameliorates TSH-impaired defensive barrier of artery, Redox Biology, 2018, May, 15: 418-434. IF 10.787 10.Qi Xiaoyi; Guo Yanjing; Yu Chunxiao; Zhao Lifang; Song Yongfeng,Fang Li; Kong Dehuan; Zhao Jiajun*; Gao Ling*, Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice, Diabetologia, 2018,May, 61(5): 1180-1192. IF 10.46 11.Jun Zhang#, Wenyi Yang#, Yue Zhu, Zhanbin Li, Yin Zheng, Yufei Zhang, Weisong Gao, Xinge Zhang, Zhongming Wu*, Ling Gao*。Microenvironment-induced programmable nanotherapeutics restore mitochondrial dysfunction for the amelioration of non-alcoholic fatty liver disease. Acta Biomater. 2025 Mar 1:194:323-335. IF 9.4 12.Yin Zheng, Mingyue Wang, Xinge Zhang, Zhongming Wu*, Ling Gao *. A bacteria-responsive nanoplatform with biofilm dispersion and ROS scavenging for the healing of infected diabetic wounds. Acta Biomaterialia. 193 (2025) 545–558. IF 9.4

更多相关视频